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Lentinus cladopus LC4 produced at least eight antimicrobial compounds (ACs) which are active against plant
and human pathogens. Three ACs in its crude mycelial were extracted with methanol and partial purification
was carried out with silicic acid column chromatography and by thin layer chromatography (PTLC). The
antimicrobial activity was tested by paper disc method and antibiographic method. The chromatography purification
eluted with dichloromethane containing 5% methanol gave one active fraction (FII). This fraction which was
active against X. campestris pv. glycines and showing two inhibition zones  against Bacillus subtilis on bioautographic
plates with the Rfs 0.8 and 0.7. FI and FIII fractions eluted with dichloromethane containing 0 and 10% methanol
performed one inhibition zone with Rfs 0.8 and 0.7 respectively. However, their activities were lower than that of
FII fraction. The PLTC purification gave one separate fraction with Rf value of 0.73 and it was active against X.
campestris pv. glycines. The compound of Rf 0.73 fraction should be further studied using TLC and HPLC to obtain
the pure substance for molecule characterization.
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INTRODUCTION
Mushrooms have been applied throughout the world
as both food and medicine for thousands of years. Two
thousand years have passed since the first century Greek
physician Dioscorides included the polypore Fomitopsis
officinalis, as a treatment for tuberculosis, in his De
Materia Medica published approximately 65 C.E. The
potential of mushrooms (macrofungi) as sources of
antibiotics was reported by Anchel, Hervey, Wilkins in
1941 (Sandven 2000). They tested the extracts of fruiting
bodies and mycelia culture from over 200 species. Several
compounds that inhibit the growth of a large spectrum of
saprophytic and phytopathogenic fungi and bacteria were
isolated from basidiomycetes (Anke 1989; Coletto et al.
1994; Anke 1995; Bianco & Striano 2000; Smania et al.
2001; Badalyan et al. 2008; Minato 2008). The study on
polypores, such as several species of Ganoderma,
Trametes versicolor, T. Marianna, T. cingulata, and
Laetiporus sulphureus and gilled mushrooms, such as P.
ostreatus, Lentinus connatus, and Lentinula edodes
showed either the antibacterial, anti-candida, antiviral or
cytotoxic activities (Hirasawa et al. 1999; Gerasimenya et
al. 2002; Babitskaya et al. 2003; Rukachaisirikul et al. 2005;
Turkoglu et al. 2006; Ofodile et al. 2008). Despite their
potential and enormous diversity in tropical ecosystems,
few studies aiming at the discovery of bioactive
compounds from mushrooms were conducted in
Indonesia.
A number of species of Lentinus are edible and
supposedly therapeutic properties and traditionally are
used by local peoples, several among them are L. sajor-
caju, L. squarrosulus, L. badius (Pegler 1983), and L.
tuberregium (Isikhuemhen et al. 2000). Several other
antimicrobial compounds have already been discovered
from L. crinitus (Abraham & Abate 1995), L. degener
(Anchel et al. 1948), and L. adhaerens (Lauer et al. 1991).
In addition several metabolites were produced by Lentinus
as the fragrance compounds from L. lepideus (Hanssen
& Abraham 1987), the antiaggregant compound from L.
adhaerens (Lauer et al. 1991), and the antitumor
substances from L. lepideus and L. trabeum (Jong & Gantt
1987).
On silica gel thin-layer chromatograms, the crude
extracts of tropical Lentinus were separated into several
bioautographic spots; for the filtrate extracts of L.
squarrosulus 55A into three spots (Rfs 0.75, 0.50, and
0.17), the mycelial extracts of L. sajor-caju LSC8 into two
spots (Rfs 0.77 and 0.54), the mycelial extract of L. torulosus
LU3 into two spots (Rfs 0.77and 0.48), the filtrate extracts
of L. cladopus LC6 into one spot (Rf 0.76) but the mycelial
extracts of this mushroom separated into two spots (Rfs
0.79 and 0.54), the filtrate and mycelial extracts of L.
cladopus LC4 into three spots respectively (Rfs 0.75, 0.61,
and 0.45  for the filtrate extract and Rfs 0.83, 0.73, and 0.60
for mycelial extract) (Sudirman 2005), while the fruiting
body extract into two spots (Rfs 0.68 and 0.08) (Sudirman
2009, unpublished data).
This work is part of a screening program aiming to
discover new bioactive metabolites from tropical
mushrooms. We reported here the results of purification
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process of three antimicrobial compounds of L. cladopus
LC4 by column chromatography and preparative thin layer
chromatography.
MATERIALS  AND  METHODS
Fungal Isolate. L. cladopus LC4 isolate was obtained
by mating of two compatible monokaryon mycelia come
from spores which were isolated from a fruiting body of L.
cladopus LC. Bacterial plant pathogens, Xanthomonas
campestris pv. glycines and Bacillus subtilis were obtained
from Bacteriology Laboratory, Research Center for
Agriculture Biotechnology and Genetic Resources
(BALITBIOGEN), Bogor, Indonesia and Laboratory of
Industrial Microbiology, ENSAIA, Nancy, French
respectively.
Mycelial Production. Mycelia were obtained from
liquid cultures of L. cladopus LC4. One inoculant of
7 mm diameter mycelium of this isolate was inoculated on
the surface of 100 ml of EMP media (malt extract 15 g,
bacteriological peptone 5 g, glucose 20 g, distilled water
1 l) in 250 ml of Erlenmeyer flask. All cultures were
incubated at 35 oC at static condition for 30 days.
Mycelial Extraction. Mycelia of the cultures were
separated from the culture filtrate using filter paper.
Mycelia were ground with a mortar and then extracted
twice with 50 ml methanol  and agitated overnight on a
rotary shaker for each extraction. The extracts were
separated from the mycelia with fritted glass filter no. 3
and then dried under vacuum on a 30 oC water bath and a
rotary evaporator, then they were redissolved in methanol.
Activity Test of Extracts. The method used for extract
activity test was paper disc method using Xanthomonas
campestris pv. glycines as target microbe (Sudirman et al.
1994). The test media for this bacterium was Luria Bertani
Agar (LBA) (tryptone 5 g, yeast extract 2.5 g, NaCl 5 g, agar
7.5 g, distilled water 1 l).
Cell suspensions of X. campestris pv. glycines
obtained by inoculating one loop inoculator of bacterial
colony to 20 ml Luria Bertani Broth. The cultures were
agitated on a shaker at room temperature for two days. As
much as 100 μl of the cell suspension were added into
100 ml of LBA media. Then the 10 ml of the media were
poured on a Petri dish.
The extracts were prepared by placing 100 μl on a
13 mm paper disc. The treatment control was the discs
with similar solvents without the extracts. The discs were
dried on air in order to remove the solvents, sterilized with
UV ray (254 nm) for 30 min and then placed on the surface
of LBA media containing X. campestris pv. glycines. The
media were then incubated at 10 oC for 3-4 hours in order
to diffuse the extracts into agar media. After incubation at
room temperature (28-30 oC) for two days, inhibition
activities of extracts were estimated by measuring the
diameters of inhibition zones.
Partial Purification with Column Chromatography.
Three active compounds [Rf values of 0.83 (LC4-3 fraction),
0.73 (LC4-2 fraction), and 0.60 (LC4-1 fraction)] were
purified by silicic acid column chromatography.  The crude
extract were applied to a column (2.1 x 65 cm) filled with
silica gel silicic acid (Merck 60, Nr. 9385) mixed with celite
(BDH 15284) (1:1, w:w) and eluted with steps of increasing
concentrations of methanol in dichloromethane: 0, 5, 10,
20, 60, 100%. The fractions were tested against X.
campestris pv. glycines by paper disc method, detected
by bioautography against B. subtilis and by being viewed
under ultraviolet radiation at 366 nm (Sudirman 2005).
Detection of Extract Separation by Bioautography
Method using Bacillus subtilis. The media for B. subtilis
was Tryptone Glucose Yeast (TGY) (tryptone 5 g, yeast
extract 5 g, glucose 1 g, K2HPO4 1 g, agar 7.5 g, distilled
water 1 l). The cell suspensions of B. subtilis were obtained
by growing 100 ìl of stock suspension on 25 ml of TGY
media in Petri dish and incubated at 28 oC for 15 days.
Each Petri dish was then added with 3 ml of sterile distilled
water, the suspension was then scrapped with glass rod,
filtered with sterile cotton and pausterized three times at
60 oC for 30 min. One hundred microliter of this cell
suspension were added to 100 ml of TGY media and then
the media were poured on TLC plate explained below.
Thin-layer chromatography (TLC) analysis was carried
out using silica gel plates (Merck 60 F 254, 0.1-mm thick,
20 x 5 cm). All fractions from column chromatography
were deposited as spots and developed in a butanol-acetic
acid-water mixture (3:1:1, vol:vol:vol). Dry chromatograms
were covered with 15 ml TGY medium containing B. subtilis
and then incubated at 10 oC for 3-4 hours. The location of
inhibition zones were estimated by measuring the Rf values
of inhibition spots (Sudirman et al. 1994).
Partial Purification with Preparative thin Layer
Chromatography. Three active compounds [Rf values were
0.83 (LC4-3 fraction), 0.73 (LC4-2 fraction), and 0.60 (LC4-
1 fraction)] were further purified as well by preparative
thin layer chromatography by using larger and thicker
silica gel plates (Merck, Kieselgel G Nr. 7731, 2 mm thick,
20 x 20 cm). Crude mycelial extracts were deposited as
spots along plates and developed in a butanol-acetic acid-
water mixture (3:1:1, vol:vol:vol). Based on LC4-3, LC4-2,
and LC4-1 Rfs, silica gels containing each active fraction
were removed, extracted with methanol, and then dried
under vacuum in a 30 oC water bath and a rotary evaporator,
then redissolved in methanol. Each fraction was tested
against X. campestris pv. glycines, detected by
bioautography against B. subtilis and by being viewed
under ultraviolet radiation at 366 nm (Sudirman 2005).
RESULTS
Antimicrobial Activity of Lentinus cladopus LC4
Mycelial Extracts. On the basis of experimental evidence,
it appears that mycelial extract of tropical L. cladopus LC4
was considered to be further investigated due to its strong
antimicrobial activity against X. campestris pv. glycines,
a pathogen of soybean bacterial pustule disease with
inhibition zone diameter up to 39 mm.
Partial Purification with Column Chromatography.
Three fractions separated by silicic acid column
chromatography i.e. FI, FII, and FIII eluted with
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dichloromethane containing 0, 5, and 10% methanol
respectively were active to inhibit growth of X. campestris
pv. glycines. And the highest inhibition activity was
performed by FII fraction (eluted with 5% methanol)
(Figure 1). These three fractions were eluted with small
volumes of eluents compare with other fractions, and they
had lower fraction weights and concentrations (Figure 2).
Other fractions i.e. FIV, FV, and FVI eluted with
dichloromethane containing 20, 60, and 100% methanol
respectively were not active despite they had higher
concentrations, especially the FIV fraction.
All fractions on the chromatogram plates were
separated into several spots (Figure 3). F1 fraction
performed one florescence of active inhibition spot at Rf
value of 0.8. FII fraction performed two florescence of
active inhibition spots at Rf values of 0.8 and 0.7. And FIII
fraction performed one florescence of active inhibition
spot at Rf value of 0.8. But other fractions i.e. FIV, FV, and
FVI fractions did not perform any active inhibition spot. Partial Purification with Preparative Thin Layer
Chromatography. From three active compounds isolated
from L. cladopus LC4 mycelia, LC4-2 fraction gave one
inhibition zone with Rf value of 0.73. This fraction was
florescence under ultraviolet radiation at 366 nm. LC4-3
fraction performed two inhibition zones with Rf values of
0.81 and 0.70 respectively. And LC4-1 fraction performed
two inhibition zones with Rf values of 0.70 and 0.60
respectively. However, only LC4-2  fraction was active to
inhibit growth of X. campestris pv. glycines.
DISCUSSION
The bioautographic results with B. subtilis showed
that the crude extracts of tropical Lentinus spp. contained
at least two active compounds. The previous results
showed that L. cladopus LC4 produced eight active
compounds isolated from fruiting body, mycelia, and
culture filtrate extracts. Mycelial extract of L. cladopus
LC4 contained three active compounds with Rf values of
0.83, 0.73, and 0.60 (Sudirman 2005). In this investigation,
the compound with Rf 0.60 was not eluted from
chromatographic column. This compound might be
distributed in small quantity in each fraction of FV (Figure
3), as a consequence, the active compound can not be
detected by bioautography method.
The separation of the active compounds isolated from
Lentinus cladopus LC4 mycelial extract reduced the
activity of each active compound against X. campestris
pv. glycines as shown by FI and FIII fractions which each
fraction contained one active compound with similar Rf
values of 0.8. It was different from FII fraction which
contained two active compounds with Rf values of 0.8
and 0.7 and it was more active against X. campestris pv.
glycines than FI and FIII fractions. Different results with
purification by preparative thin layer chromatography,
only LC4-2 fraction containing one active compound with
Rf value of 0.73 was active against this bacteria. Based on
this result, it seems that mixture of compounds with Rf
values of 0.8 and 0.7 will give stronger activity. Separation
of these three antimicrobial compounds will be continued
Figure 1. Partial purification of active compounds isolated from of
Lentinus cladopus LC4 myclia by silicic acid column
chromatography eluted with dichloromethane containing
methanol 0, 5, 10, 20, 60, and 100% and black bars of FI,
FII, FIII, FIV, FV, and FVI indicated obtained fractions
respectively. White bars indicated inhibition zone of the
fractions against Xanthomonas campestris pv. glycines.
(vertical bars indicated standar deviation, n = 5).
Figure 2. Elution profile of mycelial extract of Lentinus cladopus
LC4 on silicic acid column chromatography eluted with
dichloromethane containing methanol 0, 5, 10, 20, 60,
and 100%  and FI, FII, FIII, FIV, FV, and FVI indicated
name of obtained fractions respectively.
FI FII
FIII
FIV
FV
FVI
  FI  FII  FIII    FIV                             FV                         FVI
Figure 3. Partial purification of active compounds isolated from
Lentinus cladopus LC4 mycelia by silicic acid column
chromatography eluted by dichloromethane containing
methanol 0% (FI), 5% (FII), 10% (FIII), 20% (FIV),
60% (FV), and 100% (FVI). The fractions were viewed
under ultraviolet radiation at 366 nm, tested against
Xanthomonas campestris pv. glycines (Xc) and detected
by bioautography method using Bacillus subtilis for
giving Rf values of inhibition zones.
to obtain the pure compounds for molecule characterization
and will be focus on LC4-2 fraction.
All extracts of tropical Lentinus tested against B.
subtilis always produce inhibition zones, except for the
culture extract of L. squarrosulus LP9 (Sudirman 2009,
unpublished data). B. subtilis was used for screening for
bioautography instead of using X. campestris pv. glycines
due to its sensitivity to antimicrobial compounds and its
ability to grow on chromatogram plates.
The crude mycelial extract of L. cladopus LC4 had
been tested in vivo against X. campestris pv. glycines on
soybean leaves and seeds. The application of crude extract
on the soybean leaves and on the healthy soybean seeds
gave the highest inhibition of pustule formation as
indicator of disease symptom, however it gave negative
results for unhealthy seeds. Based on this result, the crude
extract was supposedly to be used for preventive and
curative application (Sudirman 2003, unpublished data).
Recently the formula of biofungicide namely Bio-LC4 was
formulated based on crude extract of L. cladopus LC4 and
it has been patented. This formula was tested on the
seedlings of flowering white cabbage (Brassica rapa).
The results showed that the seedlings grown on the media
containing the formula were less infected by disease than
those grown without the formula (unpublished data). This
research is still in progress in order to obtain the best
formula for other pathogen targets.
It is suggested to screen edible mushrooms for anti-
Candida albicans which could attack AIDS patients.
Unfortunately, the fruiting body extracts of L. torulosus
LU3 and L. cladopus LC6 were not active against this
pathogen. Polysaccharide namely PSK from Trametes
versicolor could inhibit the growth of C. albicans
(Tsukagoshi et al. 1984). Other active compounds of
polysaccharides such as lentinan extracted from shiitake
mushroom (Lentinula edodes) and schizophyllan
extracted from the split-gill mushroom (Schizophyllum
commune) could inhibit growth of C. albicans and
Saccharomyces aureus (Wasser & Weis 1999). Many non-
edible mushrooms such as Paecilomyces cicadidae are
potential in producing antimicrobial compounds as
reported by Chen et al. (2008). Rosa et al. (2003) tested
also the culture extract of Phellinus sp. against Bacillus
cereus. Suay et al. (2000) found that all of the
Ganodermataceae were specifically effective against B.
subtilis. G. applanatum and also showed antimicrobial
activity against Staphylococcus aureus, however they
were less active against Gram-negative bacteria i.e. E. coli,
and Pseudomonas aeruginosa (Smania et al. 2001).
Antimicrobial activity of the filtrate extract of L.
squarrosulus 55A against R.lignosus F1 was reported,
however the activity was due to the production of oxalic
acid that was probably responsible for half of inhibitory
effect of the filtrate extract. The active compound of
Lentinus Ls2, had been characterized (Sudirman et al.
1994). Some properties of the Ls2 compound, such as the
hydrophilic character; reactions with chromogenic
reactants of sugars suggested that the molecule contains
a glycosidic part; and the presence of alcoholic functions.
There might be possibility to find a strong active
compound from other species of tropical Lentinus
excluding L. cladopus LC4 which was being studied further.
It is also interested to continue the research on L. sajor-
caju LSC8 which produce two antimicrobial compounds
from its mycelial extract (Sudirman 2005) as well as to study
L. squarosulus LP9. Both mushrooms are edible and active
against enteropathogenic Escherichia coli (EPEC) which
were resistant to several antibiotics (Sudirman 2009,
unpublished data), so that they can be used either as
food or medicine.
The purification of LC4 fraction (Rf 0.73) from crude
extract will be further conducted using PTLC for better
purity of the substances. And final purification of LC4-2
fraction to obtain better purity of the compound will be
further conducted using PTLC and high performance
liquid chromatography (HPLC). The pure compounds are
necessary for characterization and determination of
molecule structures. For this purposes, the pure extract
will be characterized by chemical reactions, ultraviolet
spectroscopy, infrared spectroscopy, proton nuclear
magnetic resonance spectroscopy, and other
physicochemical analysis.
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